285 related articles for article (PubMed ID: 28962521)
1. Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.
Borland MG; Yao PL; Kehres EM; Lee C; Pritzlaff AM; Ola E; Wagner AL; Shannon BE; Albrecht PP; Zhu B; Kang BH; Robertson GP; Gonzalez FJ; Peters JM
Toxicol Sci; 2017 Oct; 159(2):436-448. PubMed ID: 28962521
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.
Borland MG; Kehres EM; Lee C; Wagner AL; Shannon BE; Albrecht PP; Zhu B; Gonzalez FJ; Peters JM
Toxicology; 2018 Jul; 404-405():25-32. PubMed ID: 29729928
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
Yessoufou A; Wahli W
Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis.
Ji Y; Li H; Wang F; Gu L
Front Pharmacol; 2018; 9():648. PubMed ID: 30002625
[TBL] [Abstract][Full Text] [Related]
7. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
9. The Role of PPARβ/δ in Melanoma Metastasis.
Lim JCW; Kwan YP; Tan MS; Teo MHY; Chiba S; Wahli W; Wang X
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241392
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
11. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms.
Yao PL; Chen LP; Dobrzański TP; Phillips DA; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Oncotarget; 2015 Nov; 6(34):36319-37. PubMed ID: 26431381
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
15. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
[TBL] [Abstract][Full Text] [Related]
16. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
[TBL] [Abstract][Full Text] [Related]
17. Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival.
Ma JJ; Monsivais D; Dyson MT; Coon JS; Malpani S; Ono M; Zhao H; Xin H; Pavone ME; Kim JJ; Chakravarti D; Bulun SE
Horm Cancer; 2013 Dec; 4(6):358-70. PubMed ID: 23943160
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
19. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
[TBL] [Abstract][Full Text] [Related]
20. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines.
He P; Borland MG; Zhu B; Sharma AK; Amin S; El-Bayoumy K; Gonzalez FJ; Peters JM
Toxicology; 2008 Dec; 254(1-2):112-7. PubMed ID: 18950674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]